Stryker Corporation
SYK
#145
Rank
โ‚น12.299 T
Marketcap
โ‚น32,161
Share price
0.13%
Change (1 day)
2.45%
Change (1 year)
Categories
Stryker Corporation is an American company that manufactures orthopedic and surgical implants and instruments as well as products for patient transportation.

P/E ratio for Stryker Corporation (SYK)

P/E ratio as of December 2025 (TTM): 45.7

According to Stryker Corporation's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 45.7121. At the end of 2024 the company had a P/E ratio of 45.7.

P/E ratio history for Stryker Corporation from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202445.728.92%
202335.4-7.52%
202238.3-21.39%
202148.7-11.03%
202054.854.14%
201935.5130.57%
201815.4-70.53%
201752.3111.35%
201624.713.2%
201521.9-58.37%
201452.5112.35%
201324.779.24%
201213.8

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Smith & Nephew
SNN
28.7-37.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Medtronic
MDT
26.6-41.80%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Boston Scientific
BSX
48.7 6.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
35.9-21.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-29.8-165.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
-2.14-104.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Hill-Rom
HRC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
-0.1796-100.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Waters Corporation
WAT
35.1-23.22%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.